4978 — ReproCell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for ReproCell, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,642	6,379	6,567	3,942	6,508
Net Total Accounts Receivable
Net Total Receivables	348	446	421	464	332
Total Inventory
Total Other Current Assets
Total Current Assets	5,379	7,182	7,399	4,896	7,329
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	97.8	101	200	242	282
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	8,095	8,356	9,053	9,671	9,652
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	827	750	678	641	617
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	845	781	741	686	806
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	7,251	7,575	8,312	8,985	8,847
Total Liabilities & Shareholders' Equity	8,095	8,356	9,053	9,671	9,652
Total Common Shares Outstanding